Myriam Chimen

Myriam Chimen

Auto-generated profile, based on publicly available information

Myriam Chimen

Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham , Birmingham B15 2TT

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 December 2011 in Diabetologia
Verified
Journal Article
Closed access
PDF file
MCM. Chimen
M. Chimen
AKA. Kennedy
A. Kennedy
KNK. Nirantharakumar
K. Nirantharakumar
TPT. T. Pang
T. T. Pang
RAR. Andrews
R. Andrews
PNP. Narendran
P. Narendran

26 February 2014 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
ARAnne L. Robertson
Anne L. Robertson
GHGeoffrey R. Holmes
Geoffrey R. Holmes
ABAleksandra N. Bojarczuk
Aleksandra N. Bojarczuk
JBJoseph Burgon
Joseph Burgon
CLCatherine A. Loynes
Catherine A. Loynes
SRStephen Renshaw
Stephen Renshaw
The proresolution therapeutic tanshinone IIA drives inflammation resolution by reverse migration.

21 July 2015 in Platelets
Verified
Journal Article
Open access
PDF file
GRGeorge Edward Rainger
George Edward Rainger
MCMyriam Chimen
Myriam Chimen
MHMatthew J. Harrison
Matthew J. Harrison
CYClara M. Yates
Clara M. Yates
PHPaul Harrison
Paul Harrison
GNGerard B. Nash
Gerard B. Nash
Besides their role in the formation of thrombus during haemostasis, it is becoming clear that platelets contribute to a number of other processes within the vasculature. Indeed, the integrated function of the thrombotic and inflammatory systems, which results in platelet-mediated recruitment of leukocytes, is now considered to be of great importance in the propagation, progression and pathogenesis of atherosclerotic disease of the arteries. There are three scenarios by which platelets can interact with leukocytes: (1) during haemostasis, when platelets adhere to and are activated on sub-endothelial matrix proteins exposed by vascular damage and then recruit leukocytes to a growing thrombus. (2) Platelets adhere to and are activated on stimulated endothelial cells and then bridge blood borne leukocytes to the vessel wall and. (3) Adhesion between platelets and leukocytes occurs in the blood leading to formation of heterotypic aggregates prior to contact with endothelial cells. In the following review we will not discuss leukocyte recruitment during haemostasis, as this represents a physiological response to tissue trauma that can progress, at least in its early stages, in the absence of inflammation. Rather we will deal with scenarios 2 and 3, as these pathways of platelet–leukocyte interactions are important during inflammation and in chronic inflammatory diseases such as atherosclerosis. Indeed, these interactions mean that leukocytes possess means of adhesion to the vessel wall under conditions that may not normally be permissive of leukocyte–endothelial cell adhesion, meaning that the disease process may be able to bypass the regulatory pathways which would ordinarily moderate the inflammatory response.

15 March 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAmy Kennedy
Amy Kennedy
KNKrishnarajah Nirantharakumar
Krishnarajah Nirantharakumar
MCMyriam Chimen
Myriam Chimen
TPTerence T. Pang
Terence T. Pang
KHKarla Hemming
Karla Hemming
PNParth Narendran
Parth Narendran
Whilst regular exercise is advocated for people with type 1 diabetes, the benefits of this therapy are poorly delineated. Our objective was to review the evidence for a glycaemic benefit of exercise in type 1 diabetes. Electronic database searches were carried out in MEDLINE, Embase, Cochrane’s Controlled Trials Register and SPORTDiscus. In addition, we searched for as yet unpublished but completed trials. Glycaemic benefit was defined as an improvement in glycosylated haemoglobin (HbA1c). Both randomised and non-randomised controlled trials were included. Thirteen studies were identified in the systematic review. Meta-analysis of twelve of these (including 452 patients) demonstrated an HbA1c reduction but this was not statistically significant (standardised mean difference (SMD) −0.25; 95% CI, −0.59 to 0.09). This meta-analysis does not reveal evidence for a glycaemic benefit of exercise as measured by HbA1c. Reasons for this finding could include increased calorie intake, insulin dose reductions around the time of exercise or lack of power. We also suggest that HbA1c may not be a sensitive indicator of glycaemic control, and that improvement in glycaemic variability may not be reflected in this measure. Exercise does however have other proven benefits in type 1 diabetes, and remains an important part of its management.

20 April 2015 in Nature Medicine
Verified
Journal Article
Open access
PDF file
MCMyriam Chimen
Myriam Chimen
HMHelen McGettrick
Helen McGettrick
BABonita Apta
Bonita Apta
SKSahithi J Kuravi
Sahithi J Kuravi
CYClara M Yates
Clara M Yates
GRGeorge Edward Rainger
George Edward Rainger
B cell–mediated inhibition of T cell trafficking is impaired in inflammatory disease. During an inflammatory response, lymphocyte recruitment into tissue must be tightly controlled because dysregulated trafficking contributes to the pathogenesis of chronic disease. Here we show that during inflammation and in response to adiponectin, B cells tonically inhibit T cell trafficking by secreting a peptide (PEPITEM) proteolytically derived from 14.3.3 zeta delta (14.3.3.ζδ) protein. PEPITEM binds cadherin-15 on endothelial cells, promoting synthesis and release of sphingosine-1 phosphate, which inhibits trafficking of T cells without affecting recruitment of other leukocytes. Expression of adiponectin receptors on B cells and adiponectin-induced PEPITEM secretion wanes with age, implying immune senescence of the pathway. Additionally, these changes are evident in individuals with type 1 diabetes or rheumatoid arthritis, and circulating PEPITEM in patient serum is reduced compared to that of healthy age-matched donors. In both diseases, tonic inhibition of T cell trafficking across inflamed endothelium is lost. Control of patient T cell trafficking is re-established by treatment with exogenous PEPITEM. Moreover, in animal models of peritonitis, hepatic ischemia-reperfusion injury, Salmonella infection, uveitis and Sjögren's syndrome, PEPITEM reduced T cell recruitment into inflamed tissues.

1 April 2017 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MCMyriam Chimen
Myriam Chimen
CYClara M. Yates
Clara M. Yates
HMHelen McGettrick
Helen McGettrick
LWLewis S. C. Ward
Lewis S. C. Ward
MHMatthew J. Harrison
Matthew J. Harrison
GRGeorge Edward Rainger
George Edward Rainger
Two major monocyte subsets, CD14+CD16− (classical) and CD14+/dimCD16+ (nonclassical/intermediate), have been described. Each has different functions ascribed in its interactions with vascular endothelial cells (EC), including migration and promoting inflammation. Although monocyte subpopulations have been studied in isolated systems, their influence on EC and on the course of inflammation has been ignored. In this study, using unstimulated or cytokine-activated EC, we observed significant differences in the recruitment, migration, and reverse migration of human monocyte subsets. Associated with this, and based on their patterns of cytokine secretion, there was a difference in their capacity to activate EC and support the secondary recruitment of flowing neutrophils. High levels of TNF were detected in cocultures with nonclassical/intermediate monocytes, the blockade of which significantly reduced neutrophil recruitment. In contrast, classical monocytes secreted high levels of IL-6, the blockade of which resulted in increased neutrophil recruitment. When cocultures contained both monocyte subsets, or when conditioned supernatant from classical monocytes cocultures (IL-6hi) was added to nonclassical/intermediate monocyte cocultures (TNFhi), the activating effects of TNF were dramatically reduced, implying that when present, the anti-inflammatory activities of IL-6 were dominant over the proinflammatory activities of TNF. These changes in neutrophil recruitment could be explained by regulation of E-selectin on the cocultured EC. This study suggests that recruited human monocyte subsets trigger a regulatory pathway of cytokine-mediated signaling at the EC interface, and we propose that this is a mechanism for limiting the phlogistic activity of newly recruited monocytes.